The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...
London man Dan Godley survived stage three pancreatic cancer with support from his fiancée, a dachshund puppy and groundbreaking treatment. He ...
MedPage Today on MSN
Overcoming CDK4/6 inhibitor resistance in HR-positive/HER2-negative breast cancer
The optimal approach to treatment in the post-CDK4/6 inhibitor setting remains undefined, but multiple strategies have ...
AstraZeneca & Daiichi Sankyo’s Enhertu gets US FDA breakthrough therapy designation in US as post-neoadjuvant therapy for patients with HER2-positive early breast cancer ...
AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy Designation (BTD) in the US for adult patients with HER2-positive early breast cancer ...
Programme testing for BRCA mutation to resume next year after successful launch results, Health Secretary tells JC ...
Tolmar, Inc. (Tolmar) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Rubraca® (rucaparib), enabling its use prior to chemotherapy for eligible ...
Angelina Jolie, the renowned actress and philanthropist, has once again boosted breast cancer prevention by openly exposing ...
HealthDay on MSN
San Antonio Breast Cancer Symposium, Dec. 9 to 12
The annual San Antonio Breast Cancer Symposium was held from Dec. 9 to 12 in San Antonio. Attendees included medical ...
13d
Mum's heartbreaking wish for her daughters after a subtle sign led to her gut-wrenching diagnosis
Bec Pickering, from Melbourne, has just one wish for her two young daughters after a devastating diagnosis turned her own ...
With Strand Life Sciences, Reliance is pushing genetic testing toward the mainstream. Incumbents, regulators and doctors are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback